![Travis Whitfill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Travis Whitfill
Founder at
AZITRA, INC.
Net worth: 385 $ as of 2026-05-30
Profile
Travis Whitfill is the founder of Azitra, Inc., founded in 2014, holding the titles of Chief Operating Officer, Secretary & Director.
Dr. Whitfill is currently a Professor at Yale University since 2018.
Former jobs include Director at 410 Medical, Inc. from 2017 to 2019, Director at Immusoft Corp., Director at SIRPant Immunotherapeutics, Inc. from 2021 to 2023, Independent Director at IN8bio, Inc. from 2018 to 2025, Partner at BIOS Equity Partners LP from 2015 to 2023, and Partner at BIOS Capital Management LP from 2015 to 2023.
Education history includes undergraduate studies at Dallas Baptist University, graduate studies at Yale University, and graduate studies at University College London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AZITRA INC 0.01% | 2026-04-23 | 1,676 ( 0.01% ) | 385 $ | 2026-05-30 |
Travis Whitfill active positions
| Companies | Position | Start |
|---|---|---|
| AZITRA, INC. | Founder | 2014-01-01 |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2018-02-28 |
Former positions of Travis Whitfill
| Companies | Position | End |
|---|---|---|
| IN8BIO, INC. | Director/Board Member | 2025-05-08 |
BIOS Capital Management LP
 BIOS Capital Management LP Investment ManagersFinance BIOS Partners invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and medical device sectors. It provides financing for early and later stage capital requirements. | Private Equity Investor | 2023-05-31 |
BIOS Equity Partners LP
 BIOS Equity Partners LP Investment ManagersFinance Functions as private equity firm | Corporate Officer/Principal | 2023-05-31 |
SIRPant Immunotherapeutics, Inc.
 SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops adoptive cell therapy | Director/Board Member | 2023-05-31 |
410 Medical, Inc.
 410 Medical, Inc. Medical SpecialtiesHealth Technology Develops medical devices | Director/Board Member | 2019-06-30 |
Training of Travis Whitfill
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
91
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Immusoft Corp.
 Immusoft Corp. Medical/Nursing ServicesHealth Services Provides disease curing services through immune cells | Health Services |
410 Medical, Inc.
410 Medical, Inc. Medical SpecialtiesHealth Technology Develops medical devices | Health Technology |
Dallas Baptist University
 Dallas Baptist University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BIOS Capital Management LP
BIOS Capital Management LP Investment ManagersFinance BIOS Partners invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and medical device sectors. It provides financing for early and later stage capital requirements. | Finance |
Azitra, Inc.
 Azitra, Inc. Pharmaceuticals: MajorHealth Technology Operates as an clinical biopharmaceutical company that develops and commercializes therapies for precision dermatology | Health Technology |
BIOS Equity Partners LP
BIOS Equity Partners LP Investment ManagersFinance Functions as private equity firm | Finance |
IN8bio, Inc.
 IN8bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on delivering a novel off-the-shelf product for the treatment of cancer | Health Technology |
SIRPant Immunotherapeutics, Inc.
SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops adoptive cell therapy | Health Technology |
- Stock Market
- Insiders
- Travis Whitfill
